Characterization of the dengue virus envelope glycoprotein expressed in Pichia pastoris
- PMID: 17502678
- DOI: 10.1007/978-1-59745-393-6_12
Characterization of the dengue virus envelope glycoprotein expressed in Pichia pastoris
Abstract
The full-length and truncated forms of recombinant envelope (E) glycoprotein from Dengue virus type 1, Singapore strain S275/90 were expressed in the yeast, Pichia pastoris, using a secretory vector. A truncated form of the E protein in which the transmembrane domain was deleted was secreted successfully into the culture medium. The E protein was also co-expressed with C and prM proteins using a non-secretory yeast vector. The co-expression of C, prM and E proteins resulted in the spontaneous formation of virus-like particles (VLPs), which were confirmed by sucrose gradient analysis and transmission electron microscopy. Furthermore, the VLPs were used to immunise rabbits, and shown to be immunogenic by immunofluorescence staining of dengue virus-infected Vero cells. The yeast-expressed E protein was treated with PNGase F, which showed that although the protein was modified by the addition of N-linked glycans, the recombinant expressed E protein was not hyperglycosylated.
Similar articles
-
Secreted expression of dengue virus type 2 full-length envelope glycoprotein in Pichia pastoris.J Virol Methods. 2003 Apr;109(1):17-23. doi: 10.1016/s0166-0934(03)00039-9. J Virol Methods. 2003. PMID: 12668263
-
Induction of virus-neutralizing antibodies and T cell responses by dengue virus type 1 virus-like particles prepared from Pichia pastoris.Chin Med J (Engl). 2012 Jun;125(11):1986-92. Chin Med J (Engl). 2012. PMID: 22884066
-
[Secreted expression of dengue virus type I envelope glycoprotein in 293T cells].Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Dec;23(6):415-7. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009. PMID: 20718342 Chinese.
-
Expression and purification of Dengue virus type 2 envelope protein as a fusion with hepatitis B surface antigen in Pichia pastoris.Protein Expr Purif. 2001 Oct;23(1):84-96. doi: 10.1006/prep.2001.1474. Protein Expr Purif. 2001. PMID: 11570849
-
Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.Methods Mol Biol. 2007;379:127-35. doi: 10.1007/978-1-59745-393-6_9. Methods Mol Biol. 2007. PMID: 17502675 Free PMC article. Review.
Cited by
-
Viral glycoproteins: biological role and application in diagnosis.Virusdisease. 2016 Mar;27(1):1-11. doi: 10.1007/s13337-015-0293-5. Epub 2016 Jan 18. Virusdisease. 2016. PMID: 26925438 Free PMC article. Review.
-
Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery.Vaccines (Basel). 2023 Feb 18;11(2):479. doi: 10.3390/vaccines11020479. Vaccines (Basel). 2023. PMID: 36851356 Free PMC article. Review.
-
Recent Developments in Recombinant Protein-Based Dengue Vaccines.Front Immunol. 2018 Aug 23;9:1919. doi: 10.3389/fimmu.2018.01919. eCollection 2018. Front Immunol. 2018. PMID: 30190720 Free PMC article. Review.
-
Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family.Vaccines (Basel). 2019 Sep 20;7(4):123. doi: 10.3390/vaccines7040123. Vaccines (Basel). 2019. PMID: 31547131 Free PMC article. Review.
-
Production of Envelope Protein-Based Virus-like Particles of DENV‑2 in and Investigation of Their Binding Interactions with Gallic Acid Derivatives of Glucose as Potential Drug Candidates.ACS Omega. 2025 Jul 21;10(30):33090-33107. doi: 10.1021/acsomega.5c02548. eCollection 2025 Aug 5. ACS Omega. 2025. PMID: 40787407 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources